MyFinsight
Home
About
Contact
cgem: the income statement
Download
Download image
Net loss
attributable to cullinan
-$50,610K
Net loss
-$50,610K
Interest income
$5,093K
Other expense, net
-$108K
Loss from operations
-$55,595K
Total operating
expenses
$55,595K
General and
administrative
$13,627K
Research and development
$41,968K
Back
Back
Income Statement
source: myfinsight.com
Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM)